APA

Koizumi W., Tanabe S., Azuma M., Ishido K., Nishimura K., Sasaki T., Nakatani K., Higuchi K., Nakayama N. & Katada C. (20091130). Impacts of fluorouracil-metabolizing enzymes on the outcomes of patients treated with S-1 alone or S-1 plus cisplatin for first-line treatment of advanced gastric cancer. : International journal of cancer.

Chicago

Koizumi Wasaburo, Tanabe Satoshi, Azuma Mizutomo, Ishido Kenji, Nishimura Ken, Sasaki Tohru, Nakatani Kento, Higuchi Katsuhiko, Nakayama Norisuke and Katada Chikatoshi. 20091130. Impacts of fluorouracil-metabolizing enzymes on the outcomes of patients treated with S-1 alone or S-1 plus cisplatin for first-line treatment of advanced gastric cancer. : International journal of cancer.

Harvard

Koizumi W., Tanabe S., Azuma M., Ishido K., Nishimura K., Sasaki T., Nakatani K., Higuchi K., Nakayama N. and Katada C. (20091130). Impacts of fluorouracil-metabolizing enzymes on the outcomes of patients treated with S-1 alone or S-1 plus cisplatin for first-line treatment of advanced gastric cancer. : International journal of cancer.

MLA

Koizumi Wasaburo, Tanabe Satoshi, Azuma Mizutomo, Ishido Kenji, Nishimura Ken, Sasaki Tohru, Nakatani Kento, Higuchi Katsuhiko, Nakayama Norisuke and Katada Chikatoshi. Impacts of fluorouracil-metabolizing enzymes on the outcomes of patients treated with S-1 alone or S-1 plus cisplatin for first-line treatment of advanced gastric cancer. : International journal of cancer. 20091130.